AIG
RARX

American International Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

American International Group’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,601
Closed -$989K – 3256
2020
Q1 		$989K Sell
20,601
-1,192
-5% -$55.5K 0.01% 1113
2019
Q4 		$1.02M Sell
21,793
-182
-0.8% -$8.04K ﹤0.01% 1320
2019
Q3 		$520K Buy
21,975
+2,064
+10% +$61.2K ﹤0.01% 1633
2019
Q2 		$599K Buy
19,911
+7,919
+66% +$181K ﹤0.01% 1600
2019
Q1 		$269K Buy
11,992
+2,481
+26% +$53.3K ﹤0.01% 2046
2018
Q4 		$173K Sell
9,511
-73
-0.8% -$1.15K ﹤0.01% 2267
2018
Q3 		$173K Buy
9,584
+174
+2% +$2.06K ﹤0.01% 2522
2018
Q2 		$94K Sell
9,410
-922
-9% -$6.37K ﹤0.01% 2821
2018
Q1 		$55K Buy
10,332
+2,413
+30% +$17.2K ﹤0.01% 2883
2017
Q4 		$67K Buy
7,919
+38
+0.5% +$467 ﹤0.01% 2882
2017
Q3 		$115K Buy
7,881
+589
+8% +$8.9K ﹤0.01% 2597
2017
Q2 		$137K Buy
7,292
+2,478
+51% +$55.9K ﹤0.01% 2519
2017
Q1 		$102K Buy
+4,814
New +$92K ﹤0.01% 2581

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

American International Group's RARX Position: Q2 2020 in Review

American International Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 20,601 shares — an estimated $989K sold.

American International Group first reported a position in RARX in Q1 2017 and held it in 13 quarters. The position peaked at $1.02M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • American International Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • American International Group sold 20,601 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $989K.
  • American International Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 13 quarters.
  • American International Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.02M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.